These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-inflammatory and immunomodulatory effects of Aries MF; Hernandez-Pigeon H; Vaissière C; Delga H; Caruana A; Lévêque M; Bourrain M; Ravard Helffer K; Chol B; Nguyen T; Bessou-Touya S; Castex-Rizzi N Clin Cosmet Investig Dermatol; 2016; 9():421-434. PubMed ID: 27877060 [TBL] [Abstract][Full Text] [Related]
3. Aquaphilus dolomiae extract counteracts the effects of cutaneous S. aureus secretome isolated from atopic children on CD4 Martin H; Laborel-Préneron E; Fraysse F; Nguyen T; Schmitt AM; Redoulès D; Davrinche C Pharm Biol; 2016 Nov; 54(11):2782-2785. PubMed ID: 27180655 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of Aquaphilus dolomiae extract-G1, ADE-G1, on tight junction barrier function in a Staphylococcus aureus-infected atopic dermatitis model. Galliano MF; Bäsler K; Caruana A; Mias C; Bessou-Touya S; Brandner JM; Duplan H J Eur Acad Dermatol Venereol; 2020 Aug; 34 Suppl 5():30-36. PubMed ID: 32870557 [TBL] [Abstract][Full Text] [Related]
5. The show must go on: an update on clinical experiences and clinical studies on novel pharmaceutical developments for the treatment of atopic dermatitis. Honstein T; Werfel T Curr Opin Allergy Clin Immunol; 2020 Aug; 20(4):386-394. PubMed ID: 32452891 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis. Nakashima C; Otsuka A; Kabashima K Exp Dermatol; 2018 Apr; 27(4):327-331. PubMed ID: 29524262 [TBL] [Abstract][Full Text] [Related]
7. Additional pharmacological activity of I-modulia and generation of two newly designed extracts of Aquaphilus dolomiae culture for dermocosmetic actives. Nguyen T; Chol B; Maitre M; Ravard-Helffer K; Farinole F; Lestienne F; Castex-Rizzi N J Eur Acad Dermatol Venereol; 2020 Aug; 34 Suppl 5():27-29. PubMed ID: 32870555 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of thymic stromal lymphopoietin production to improve pruritus and quality of life in infants and children with atopic dermatitis. Fitoussi J; Virassamynaïk S; Callejon S; Weber S; Collet E; Scalia J; Chavagnac-Bonneville M; Trompezinski S; Sayag M J Cosmet Dermatol; 2020 Aug; 19(8):2061-2069. PubMed ID: 32583610 [TBL] [Abstract][Full Text] [Related]
16. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902 [TBL] [Abstract][Full Text] [Related]
18. Weissella cibaria WIKIM28 ameliorates atopic dermatitis-like skin lesions by inducing tolerogenic dendritic cells and regulatory T cells in BALB/c mice. Lim SK; Kwon MS; Lee J; Oh YJ; Jang JY; Lee JH; Park HW; Nam YD; Seo MJ; Roh SW; Choi HJ Sci Rep; 2017 Jan; 7():40040. PubMed ID: 28067304 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of Patrinia scabiosifolia Link on the development of atopic dermatitis-like lesions in human keratinocytes and NC/Nga mice. Cha KJ; Im MA; Gu A; Kim DH; Lee D; Lee JS; Lee JS; Kim IS J Ethnopharmacol; 2017 Jul; 206():135-143. PubMed ID: 28347830 [TBL] [Abstract][Full Text] [Related]
20. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice. Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]